When.com Web Search

  1. Ads

    related to: entresto dosage for heart failure

Search results

  1. Results From The WOW.Com Content Network
  2. Sacubitril/valsartan - Wikipedia

    en.wikipedia.org/wiki/Sacubitril/valsartan

    Sacubitril/valsartan, sold under the brand name Entresto among others, is a fixed-dose combination medication for use in heart failure. It consists of the neprilysin inhibitor sacubitril and the angiotensin receptor blocker valsartan .

  3. Sacubitril - Wikipedia

    en.wikipedia.org/wiki/Sacubitril

    Sacubitril (/ s ə ˈ k juː b ɪ t r ɪ l /; INN) is an antihypertensive drug used in combination with valsartan. The combination drug sacubitril/valsartan, known during trials as LCZ696 and marketed under the brand name Entresto, is a treatment for heart failure. [1] It was approved under the FDA's priority review process for use in heart ...

  4. How much does Entresto cost with Medicare? - AOL

    www.aol.com/much-does-entresto-cost-medicare...

    Entresto helps manage chronic heart failure by reducing the effort necessary for the heart to pump blood around the body. This article explains how much a person with Medicare Part D typically ...

  5. Novartis Q4 Earnings: Revenue And EPS Beat, CEO ... - AOL

    www.aol.com/novartis-q4-earnings-revenue-eps...

    Heart failure drug Entresto sales grew 34% at constant currency, driven by strong demand and The Swiss pharma giant reported fourth-quarter adjusted earnings per share of $1.98, beating the street ...

  6. Heart failure - Wikipedia

    en.wikipedia.org/wiki/Heart_failure

    Heart failure (HF), also known as congestive heart failure (CHF), is a syndrome caused by an impairment in the heart's ability to fill with and pump blood.. Although symptoms vary based on which side of the heart is affected, HF typically presents with shortness of breath, excessive fatigue, and bilateral leg swelling. [3]

  7. Novartis loses initial bid to block generic of best-selling ...

    www.aol.com/news/novartis-loses-initial-bid...

    (Reuters) -Novartis failed to convince a federal court to block generic drugmaker MSN Pharmaceuticals from launching its own version of Novartis' blockbuster heart-failure drug Entresto, according ...

  1. Ad

    related to: entresto dosage for heart failure